Fredric Cohen
Plus aucun poste en cours
Historique de carrière de Fredric Cohen
Anciens postes connus de Fredric Cohen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Corporate Officer/Principal | 01/06/2009 | 01/03/2014 |
Crownstone Group | Analyst-Equity | 01/07/2003 | 30/03/2006 |
Directeur de la Recherche - Actions | 01/07/2003 | 30/03/2006 | |
Corporate Officer/Principal | 01/07/2003 | 30/03/2006 | |
STRONGBRIDGE BIOPHARMA | Directeur Technique/Scientifique/R&D | 18/11/2015 | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Formation de Fredric Cohen
Pennsylvania State University College of Medicine | Doctorate Degree |
Franklin & Marshall College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Corporate Officer/Principal | 3 |
Analyst-Equity | 1 |
Director of Research - Equity | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Entreprise privées | 3 |
---|---|
Crownstone Group | Finance |
Strongbridge Biopharma Plc
Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Health Technology |
- Bourse
- Insiders
- Fredric Cohen
- Expérience